Itch in psoriasis: Epidemiology, clinical aspects and treatment options

Clinical, Cosmetic and Investigational Dermatology

Volumn 2, Issue , 2009, Pages 9-13

  Prignano, Francesca ^a   Ricceri, F ^a   Pescitelli, L ^a   Lotti, T ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Efalizumab; Epidemiology; Etanercept; Itch; Phototherapy; Pruritus; Psoriasis

Indexed keywords

ANTIHISTAMINIC AGENT; CALCIPOTRIOL; EFALIZUMAB; EMOLLIENT AGENT; ETANERCEPT; STEROID;

ABNORMAL SENSATION; ARTICLE; BEHAVIOR; BIOLOGICAL THERAPY; BODY MASS; BURNING SENSATION; CHRONIC DISEASE; CONTROLLED STUDY; DIETARY INTAKE; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; PATIENT SATISFACTION; PHOTOTHERAPY; PRURITUS; PSORIASIS VULGARIS; STINGING SENSATION; STRESS; STRUCTURED QUESTIONNAIRE; ULTRAVIOLET B RADIATION; VISUAL ANALOG SCALE;

EID: 77953468074     PISSN: None     EISSN: 11787015     Source Type: Journal    
DOI: 10.2147/ccid.s4465     Document Type: Article

References (16)

1. Bernhard JD. Itch and pruritus: what are they, and how should itches be classified? Dermatol Ther. 2005;18(4):288-291.
2. Reich E, Hrechorow, Szepietowski JC. Negative influence of itching on psoriatic patients' well-being. Acta Dermato-Venereologica. 2007;87(5):478-479.
3. Sampogna F, Gisondi P, Melchi CF, et al. Prevalence of symptoms experienced by patients wuth different clinical types of psoriasis. Br J Dermatol. 2004;151:594-599.
4. Yosipovitch G, Goon A, Wee J, Chan YH, Goh CL. The prevalence and clinical characteristics of pruritus among patients with extensive psoriasis. Br J Dermatol. 2000;143:969-973.
5. Yosipovitch G. Assessment of itch: more to be learned and improvements to be made. J Invest Dermatol. 2003;121(6):XIV-XV.
6. Yosipovitch G, Goon A, Wee J, Chan YH, Goh CL. The prevalence and clinical characteristics of pruritus among patients with extensive psoriasis. Br J Dermatol. 2000;143:969-973.
7. Reich A, Szepietowski JC, Wiśnicka B, Pacan P. Does stress influence itching in psoriatic patients? Dermatology and Psychosomatics. 2003;4(3):151-155.
8. Nakamura M, Toyoda M, Morohashi M. Pruritogenic mediators in psoriasis vulgaris: comparative evaluation of itch-associated cutaneous factors. Br J Dermatol. 2003;149:718-730.
9. Gupta MA, Gupta AK, Kirkby S, et al. Pruritus in psoriasis: A prospective study of some psychiatric and dermatologic correlates. Arch Dermatol. 1988;124:1052-1057.
10. Arck P, Paus R. From the brain-skin connection: the neuroendocrineimmune misalliance of stress and itch. Neuroimmunomodulation. 2007;13(5-6):347-356.
11. Hercogova J. Topical anti-itch therapy. Dermatol Ther. 2005;18: 341-343.
12. Samson YS, Gielczyk R, Scherschun L, Lim HW. Narrow-band ultraviolet B treatment for vitiligo, pruritus and inflammatory dermatoses. Photodermatol Photoimmunol Photomed. 2003;19:164-168.
13. Dawn A, Yosipovitch G. Treating itch in psoriasis. Dermatol Nurs. 2006;18(3):227-233.
14. Reich A, Orda A, Wisnicka B, Szepietowski JC. Plasma neuropeptides and perception of pruritus in psoriasis. J Invest Dermatol. 1989;92: 126-129.
15. Wiśnicka B, Szepietowski JC, Reich A, Orda A. Histamine, substance P and calcitonin gene-related peptide plasma concentration and pruritus in patients suffering from psoriasis. Dermatology and Psychosomatics. 2004;5(2):73-78.
16. Gambichler T, Breuckmann F, Boms S, Altmeyer P, Kreuter A. Narrowband UVB phototherapy in skin conditions beyond psoriasis. J Am Acad Dermatol. 2005;52(4):660-670.